Target intelligence / Profile preview

Immunoglobulin heavy diversity 1-26 (IGHD1-26)

Target
IGHD1-26
Molecular classification
Other (Immunoglobulin gene segment, Diversity gene segment)
01

Overview

Immunoglobulin heavy diversity 1-26 (IGHD1-26) is a diversity (D) gene segment located within the immunoglobulin heavy chain locus (IGH) on chromosome 14 in humans. During B cell development, the IGHD1-26 gene can be rearranged with variable (IGHV) and joining (IGHJ) gene segments via somatic recombination to form part of the variable domain of antibodies. This genetic process underlies the generation of antibody diversity critical to adaptive immunity, but IGHD1-26 itself does not function as a receptor, enzyme, or direct drug target. Key points: IGHD1-26 is a genetic element required for the generation of antibody diversity. It has no known therapeutic targeting, direct disease association, or interaction with drugs. It is not a canonical molecular target for pharmacology or clinical diagnostics.

Other names
IGHD1-26IGHD126
02

Biological functions

Antibody repertoire diversificationJunctional diversity generation in B cellsSomatic recombination in immunoglobulin heavy chain formation

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 1-26 (IGHD1-26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 1-26 (IGHD1-26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call